Connect Plus

At Orbit Pharmaceuticals, we understand that navigating the intricate and ever-evolving regulatory environment is essential to achieving pharmaceutical success.

Our Regulatory Services are designed to provide comprehensive support, ensuring your products meet stringent global standards while maintaining operational efficiency and patient safety. With our expert guidance, you can confidently bring innovative solutions to market without compromising compliance.

Our Services Include

Regulatory Submissions and Dossier Preparation

We streamline the submission process by preparing high-quality regulatory dossiers tailored to regional and international requirements. From initial filings to lifecycle management, our team ensures accuracy, completeness, and timely delivery to regulatory authorities worldwide.

Good Manufacturing Practice (GMP) Consulting

Stay ahead of compliance demands with our GMP expertise. We offer end-to-end consulting to optimize manufacturing processes, implement best practices, and prepare for inspections, ensuring your facilities align with global GMP standards.

Quality Assurance and Risk Assessment

Our robust quality assurance framework minimizes risks and enhances product integrity. We conduct thorough risk assessments, develop mitigation strategies, and maintain rigorous quality controls to safeguard your operations and reputation.

Pharmacovigilance and Post-Market Surveillance

Patient safety is paramount. Our pharmacovigilance services monitor drug safety throughout the product lifecycle, providing adverse event reporting, signal detection, and compliance with post-market regulatory obligations.

Get in Touch

Get in touch to Report Adverse Drug Reactions (ADRs). At Orbit Pharmaceuticals, the well-being of patients is of the utmost importance. Should you encounter any unanticipated side effects or adverse responses linked to our products, we urge you to get in touch with us promptly. Your insights play a pivotal role in upholding the enduring safety and excellence of our medicinal products. To contact our specialist team for ADR reporting please complete the following:

Medical Information Direct Line

+44 (0) 203 096 2886

Medical Information E-mail

[email protected]